세계의 DNA 합성 시장 보고서(2025년)
DNA Synthesis Global Market Report 2025
상품코드 : 1810886
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

DNA 합성 시장 규모는 향후 수년간 비약적인 성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 20.4%로, 108억 7,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 DNA 합성 워크플로우에서 AI 및 자동화 도입 증가, 생명공학 기업과 학계의 협력 강화, DNA 기반 데이터 스토리지 솔루션 개발 증가, 환경적으로 지속가능한 합성 생물학에 대한 관심 증가, 유전체 혁신을 지원하는 정부 구상 증가에 기인합니다. 정부 구상 증가에 기인합니다. 이 기간 중 예상되는 주요 동향으로는 효소적 DNA 합성 기술의 발전, 합성 과정에서 클라우드 기반 바이오인포매틱스의 통합 심화, 분산형 DNA 합성 플랫폼의 출현, 합성 유전자의 오류 수정 방법의 혁신, 휴대용 온디맨드 DNA 합성 장치의 발전 등을 들 수 있습니다.

맞춤형 의료에 대한 수요 증가가 향후 DNA 합성 시장의 확대를 견인할 것으로 예측됩니다. 맞춤형 의료란 개인의 유전적 체질, 생활습관, 환경 등에 따라 치료 및 예방 전략을 조정하여 최상의 치료 결과를 얻는 것을 말합니다. 이러한 수요는 주로 유전체 기술의 발전으로 개인의 유전자 프로파일에 따른 맞춤형 치료가 가능해져 효능을 높이고 부작용을 최소화할 수 있게 되면서 증가하고 있습니다. DNA 합성은 유전자 편집, 진단 툴, 정밀 치료에 사용되는 맞춤형 DNA 염기서열을 제조할 수 있게 함으로써 맞춤형 의료에서 중요한 역할을 하고 있으며, 보다 정밀하고 효율적인 맞춤형 의료를 지원하고 있습니다. 예를 들어 2024년 2월 미국 옹호 단체인 개인화 의학 연합(Personalized Medicine Coalition)은 2023년 FDA가 희귀질환 환자를 위한 16개의 새로운 개인화 치료제를 승인했다고 보고했다(2022년 승인은 6건). 그 결과, 맞춤형 의료에 대한 수요 증가가 DNA 합성 시장의 성장을 가속하고 있습니다.

DNA 합성 시장의 주요 기업은 유전자 치료, 진단, 합성 생물학 용도를 보다 빠르고 정확하며 비용 효율적으로 개발할 수 있도록 합성 DNA 분자와 같은 혁신적인 솔루션을 만드는 데 주력하고 있습니다. 합성 DNA 분자는 연구, 진단, 생명공학에 사용하기 위해 천연 DNA를 복제하거나 변형하도록 설계된 인위적으로 만들어진 뉴클레오티드 서열입니다. 예를 들어 2025년 5월 오스트리아에 본사를 둔 합성생물학 기업 Ribbon Biolabs는 새로운 유형의 복잡한 합성 DNA 분자 MiroSynth를 발표했습니다. 이 기술은 첨단 생명공학 응용을 위해 길고 복잡한 DNA 염기서열을 높은 처리량으로 자동화하고 확장성 있게 생산할 수 있도록 도와줍니다. MiroSynth는 염기서열 조립 정확도 향상, 더 긴 염기서열 생성 능력, 복잡한 유전자 구조의 신속한 구축을 제공하여 연구, 치료제 개발, 산업 바이오테크놀러지에 이상적입니다. 적응성이 높은 설계로 다양한 워크플로우에 통합할 수 있으며, 연구개발 및 개발자들이 유전체, 합성생물학, 맞춤의료 분야의 혁신을 가속화할 수 있도록 돕습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

DNA synthesis refers to the natural or laboratory-based process of creating a new strand of deoxyribonucleic acid. Naturally, it takes place during cell division when DNA replicates to transfer genetic information to daughter cells. In biotechnology, DNA synthesis also involves the chemical fabrication of custom DNA sequences within a laboratory setting.

The primary types of DNA synthesis services include oligonucleotide synthesis, standard oligonucleotide synthesis, custom oligonucleotide synthesis, gene synthesis, custom gene synthesis, and gene library synthesis. Oligonucleotide synthesis is the chemical creation of short nucleotide sequences (oligonucleotides) used in genetic testing, research, diagnostics, and therapeutic applications. Various techniques are employed, including solid-phase synthesis, PCR-based enzymatic synthesis, and chip-based synthesis. These synthesized sequences find applications in research and development, diagnostics, therapeutics, synthetic biology, and more. The main end users encompass pharmaceutical and biotechnology companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), academic and research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The DNA synthesis market research report is one of a series of new reports from The Business Research Company that provides DNA synthesis market statistics, including the DNA synthesis industry global market size, regional shares, competitors with the DNA synthesis market share, detailed DNA synthesis market segments, market trends, and opportunities, and any further data you may need to thrive in the DNA synthesis industry. This DNA synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The DNA synthesis market size has grown exponentially in recent years. It will grow from $4.29 billion in 2024 to $5.18 billion in 2025 at a compound annual growth rate (CAGR) of 20.7%. The growth during the historic period can be attributed to the increasing use of DNA synthesis in academic genomic research, greater integration in agricultural biotechnology, rising demand for basic DNA libraries in gene function studies, expanded use of synthetic genes in vaccine development, and growing applications in infectious disease modeling.

The DNA synthesis market size is expected to see exponential growth in the next few years. It will grow to $10.87 billion in 2029 at a compound annual growth rate (CAGR) of 20.4%. The anticipated growth in the forecast period can be attributed to the increasing adoption of AI and automation within DNA synthesis workflows, enhanced collaboration between biotech companies and academic institutions, rising development of DNA-based data storage solutions, a stronger emphasis on environmentally sustainable synthetic biology, and growing government initiatives supporting genomic innovation. Key trends expected during this period include advancements in enzymatic DNA synthesis techniques, deeper integration of cloud-based bioinformatics in synthesis processes, the emergence of decentralized DNA synthesis platforms, innovations in error-correction methods for synthetic genes, and progress in portable, on-demand DNA synthesis devices.

The growing demand for personalized medicine is anticipated to drive the expansion of the DNA synthesis market in the future. Personalized medicine involves tailoring treatment and prevention strategies based on an individual's genetic makeup, lifestyle, and environment to achieve the best therapeutic results. This demand is increasing mainly due to advances in genomic technologies, which allow for treatments customized to a person's genetic profile, enhancing effectiveness and minimizing side effects. DNA synthesis plays a crucial role in personalized medicine by enabling the production of custom DNA sequences used in gene editing, diagnostic tools, and precision therapies, thereby supporting more precise, efficient, and individualized healthcare. For example, in February 2024, the Personalized Medicine Coalition, a US-based advocacy organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, compared to six approvals in 2022. Consequently, rising demand for personalized medicine is fueling growth in the DNA synthesis market.

Key players in the DNA synthesis market are focusing on creating innovative solutions such as synthetic DNA molecules to enable faster, more accurate, and cost-effective development of gene therapies, diagnostics, and synthetic biology applications. Synthetic DNA molecules are artificially constructed nucleotide sequences designed to replicate or modify natural DNA for use in research, diagnostics, and biotechnology. For instance, in May 2025, Ribbon Biolabs, an Austria-based synthetic biology company, introduced MiroSynth, a new type of complex synthetic DNA molecule. This technology facilitates high-throughput, automated, and scalable production of long, intricate DNA sequences for advanced biotech applications. MiroSynth offers enhanced accuracy in assembling sequences, the ability to create longer strands, and rapid construction of complex genetic structures, making it ideal for research, therapeutic development, and industrial biotech. Its adaptable design allows integration into various workflows, helping researchers and developers accelerate innovation in genomics, synthetic biology, and personalized medicine.

In February 2025, Maravai LifeSciences, a US-based life sciences company, acquired the DNA and RNA business of Officinae Bio for an undisclosed sum. This acquisition is intended to bolster Maravai's position in the nucleic acid production market by expanding its capabilities in high-quality DNA and RNA synthesis. Officinae Bio is an Italy-based biotechnology firm specializing in the development and manufacturing of DNA and RNA for research and therapeutic purposes.

Major players in the DNA synthesis market are Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript Biotech Corporation, Twist Bioscience Corporation, Bioneer Corporation, DNA Script, Eton Bioscience, LGC Biosearch Technologies, Ansa Biotechnologies, Synbio Technologies, Quintara Biosciences, BaseClear B.V., IBA GmbH, Elegen Corporation, Biomatik Corporation, Bio Basic Inc., Evonetix Ltd., Camena Bioscience Ltd., Jena Bioscience GmbH, and Viridos.

North America was the largest region in the DNA synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in DNA synthesis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the DNA synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA synthesis market consists of revenues earned by entities by creating synthetic DNA sequences for use in research, diagnostics, therapeutics, and biotechnology applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA synthesis market includes sales of custom DNA oligonucleotides, gene synthesis kits, reagents, and associated synthesis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Synthesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna synthesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for dna synthesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dna synthesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. DNA Synthesis Market Characteristics

3. DNA Synthesis Market Trends And Strategies

4. DNA Synthesis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global DNA Synthesis Growth Analysis And Strategic Analysis Framework

6. DNA Synthesis Market Segmentation

7. DNA Synthesis Market Regional And Country Analysis

8. Asia-Pacific DNA Synthesis Market

9. China DNA Synthesis Market

10. India DNA Synthesis Market

11. Japan DNA Synthesis Market

12. Australia DNA Synthesis Market

13. Indonesia DNA Synthesis Market

14. South Korea DNA Synthesis Market

15. Western Europe DNA Synthesis Market

16. UK DNA Synthesis Market

17. Germany DNA Synthesis Market

18. France DNA Synthesis Market

19. Italy DNA Synthesis Market

20. Spain DNA Synthesis Market

21. Eastern Europe DNA Synthesis Market

22. Russia DNA Synthesis Market

23. North America DNA Synthesis Market

24. USA DNA Synthesis Market

25. Canada DNA Synthesis Market

26. South America DNA Synthesis Market

27. Brazil DNA Synthesis Market

28. Middle East DNA Synthesis Market

29. Africa DNA Synthesis Market

30. DNA Synthesis Market Competitive Landscape And Company Profiles

31. DNA Synthesis Market Other Major And Innovative Companies

32. Global DNA Synthesis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA Synthesis Market

34. Recent Developments In The DNA Synthesis Market

35. DNA Synthesis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기